Viewing Study NCT00629967


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-01-01 @ 9:40 PM
Study NCT ID: NCT00629967
Status: COMPLETED
Last Update Posted: 2008-03-06
First Post: 2008-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-04
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2008-02-26
First Submit QC Date: None
Study First Post Date: 2008-03-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-02-26
Last Update Post Date: 2008-03-06
Last Update Post Date Type: ESTIMATED